• Fri, November 2, 2018

by: WOPRAI

David Manthey Maintained (SRCL) at Hold with Decreased Target to $56 on, Nov 2nd, 2018

by: WOPRAI

Doug Anmuth Maintained (SPOT) at Buy with Decreased Target to $200 on, Nov 2nd, 2018

by: WOPRAI

Stephen East Maintained (TMHC) at Buy with Decreased Target to $24 on, Nov 2nd, 2018

by: WOPRAI

David Driscoll Maintained (THS) at Strong Buy with Decreased Target to $55 on, Nov 2nd, 2018

by: WOPRAI

Scott Graham Maintained (THR) at Buy with Decreased Target to $29 on, Nov 2nd, 2018

by: WOPRAI

Dennis Coleman Maintained (WMB) at Strong Buy with Decreased Target to $33 on, Nov 2nd, 2018

by: WOPRAI

Christian Wetherbee Downgraded (UPS) to Hold on, Nov 2nd, 2018

by: WOPRAI

Jen Redding Downgraded (BURL) to Hold on, Nov 2nd, 2018

by: WOPRAI

J. Bruce Chan Upgraded (XPO) to Strong Buy and Held Target at $108 on, Nov 2nd, 2018

by: WOPRAI

Todd Fowler Maintained (XPO) at Buy with Decreased Target to $110 on, Nov 2nd, 2018

by: WOPRAI

Brian Ossenbeck Maintained (XPO) at Buy with Decreased Target to $130 on, Nov 2nd, 2018

by: WOPRAI

Olivia Tong Maintained (WTW) at Strong Buy with Decreased Target to $85 on, Nov 2nd, 2018

by: WOPRAI

Paul Fremont Downgraded (XEL) to Hold and Decreased Target to $47 on, Nov 2nd, 2018

by: WOPRAI

PJ Juvekar Downgraded (CC) to Hold and Decreased Target to $38 on, Nov 2nd, 2018

by: WOPRAI

Michael Rollins Maintained (CCOI) at Strong Sell with Increased Target to $42 on, Nov 2nd, 2018

by: WOPRAI

Jennifer Fritzsche Maintained (CCOI) at Hold with Increased Target to $50 on, Nov 2nd, 2018

by: WOPRAI

Timothy Thein Maintained (TEX) at Hold with Decreased Target to $38 on, Nov 2nd, 2018

by: WOPRAI

Ross Gilardi Maintained (TEX) at Sell with Decreased Target to $28 on, Nov 2nd, 2018

by: WOPRAI

Jason Gerberry Maintained (TEVA) at Sell with Increased Target to $20 on, Nov 2nd, 2018

by: WOPRAI

Richard Eastman Maintained (TRMB) at Buy with Increased Target to $47 on, Nov 2nd, 2018

by: WOPRAI

Tiffany Kanaga Upgraded (BKE) to Hold and Held Target at $19 on, Nov 2nd, 2018

by: WOPRAI

Jack Meehan Maintained (BIO) at Hold with Decreased Target to $315 on, Nov 2nd, 2018

by: WOPRAI

Rob Oliver Maintained (TYL) at Buy with Decreased Target to $250 on, Nov 2nd, 2018

by: WOPRAI

Jeffrey Meuler Maintained (ATGE) at Hold with Increased Target to $54 on, Nov 2nd, 2018

by: WOPRAI

John Kim Upgraded (AVB) to Buy on, Nov 2nd, 2018

by: WOPRAI

Kenneth Zener Upgraded (AWI) to Buy and Held Target at $76 on, Nov 2nd, 2018

by: WOPRAI

Seth Basham Maintained (W) at Hold with Decreased Target to $100 on, Nov 2nd, 2018

by: WOPRAI

Nicholas Jones Maintained (W) at Hold with Decreased Target to $105 on, Nov 2nd, 2018

by: WOPRAI

Christopher Horvers Maintained (W) at Hold with Decreased Target to $110 on, Nov 2nd, 2018

by: WOPRAI

Colin Sebastian Maintained (W) at Hold with Decreased Target to $108 on, Nov 2nd, 2018

by: WOPRAI

Michael Carroll Downgraded (VTR) to Hold and Held Target at $59 on, Nov 2nd, 2018

by: WOPRAI

Sterling Auty Upgraded (VRSN) to Hold and Increased Target to $160 on, Nov 2nd, 2018

by: WOPRAI

Walter Pritchard Maintained (VRSN) at Hold with Increased Target to $155 on, Nov 2nd, 2018

by: WOPRAI

Sterling Auty Maintained (VRSN) at Hold with Increased Target to $160 on, Nov 2nd, 2018

by: WOPRAI

Christian Wetherbee Maintained (SNDR) at Hold with Decreased Target to $25 on, Nov 2nd, 2018

by: WOPRAI

Brian Ossenbeck Maintained (SNDR) at Buy with Decreased Target to $27 on, Nov 2nd, 2018

by: WOPRAI

Benjamin Hartford Maintained (SNDR) at Buy with Decreased Target to $28 on, Nov 2nd, 2018

by: WOPRAI

Ken Hoexter Maintained (SNDR) at Sell with Decreased Target to $25 on, Nov 2nd, 2018

by: WOPRAI

Timothy Thein Maintained (AGCO) at Hold with Decreased Target to $64 on, Nov 2nd, 2018

by: WOPRAI

Jacob Kilstein Maintained (AIG) at Strong Buy with Decreased Target to $50 on, Nov 2nd, 2018

by: WOPRAI

David Ridley-Lane Maintained (CBRE) at Strong Buy with Decreased Target to $47 on, Nov 2nd, 2018

by: WOPRAI

Jonathan Raviv Maintained (CACI) at Strong Buy with Decreased Target to $205 on, Nov 2nd, 2018

by: WOPRAI

Edward Caso Maintained (CACI) at Buy with Increased Target to $210 on, Nov 2nd, 2018

by: WOPRAI

Steven Koenig Upgraded (ANSS) to Buy and Increased Target to $184 on, Nov 2nd, 2018

by: WOPRAI

Alex Kurtz Maintained (ANET) at Buy with Increased Target to $80 on, Nov 2nd, 2018

by: WOPRAI

Tim Long Maintained (ANET) at Buy with Increased Target to $74 on, Nov 2nd, 2018

by: WOPRAI

Jim Suva Maintained (ANET) at Strong Buy with Increased Target to $79 on, Nov 2nd, 2018

by: WOPRAI

Jeff Kvaal Maintained (ANET) at Hold with Increased Target to $65 on, Nov 2nd, 2018

Jack Meehan Maintained (BIO) at Hold with Decreased Target to $315 on, Nov 2nd, 2018

Jack Meehan of Barclays, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Hold with Decreased Target from $345 to $315 on, Nov 2nd, 2018.

Jack has made no other calls on BIO in the last 4 months.



There are 3 other peers that have a rating on BIO. Out of the 3 peers that are also analyzing BIO, 1 agrees with Jack's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Steve Beuchaw of "Morgan Stanley" Initiated at Hold and Held Target at $335 on, Thursday, September 20th, 2018


These are the ratings of the 2 analyists that currently disagree with Jack

  • Patrick Donnelly of "Goldman Sachs" Initiated at Strong Buy and Held Target at $350 on, Wednesday, October 17th, 2018
  • Brandon Couillard of "Jefferies" Maintained at Strong Buy with Increased Target to $355 on, Wednesday, August 8th, 2018